CNS

CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.

Why watch CNS

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest CNS news

The latest feed items from companies currently grouped under CNS.

1. 01
   2026-09-18 20:32 EST

   TEVANew Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

   Source: Teva Pharmaceutical Industries

2. 02
   2026-09-18 20:31 EST

   TEVATeva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

   Source: Teva Pharmaceutical Industries

3. 03
   2026-09-18 20:30 EST

   TEVATeva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

   Source: Teva Pharmaceutical Industries

4. 04
   2026-09-17 20:15 EST

   BIIBPhase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

   Source: Biogen

5. 05
   2026-09-17 20:01 EST

   XENEXenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

   Source: Xenon

6. 06
   2026-09-17 13:05 EST

   NMTCNeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

   Source: NeuroOne Medical Technologies

7. 07
   2026-09-17 11:00 EST

   AXSMAxsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

   Source: Axsome

8. 08
   2026-09-17 11:00 EST

   GANXGain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

   Source: Gain Therapeutics

9. 09
   2026-09-16 20:05 EST

   ANNXAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

   Source: Annexon, Inc.

10. 10
    2026-09-16 12:00 EST

    ALZNAlzamend Neuro Regains Compliance with Nasdaq Listing Standards

    Source: Alzamend Neuro

11. 11
    2026-09-16 12:00 EST

    TEVATeva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

    Source: Teva Pharmaceutical Industries

12. 12
    2026-09-16 11:00 EST

    ALKSAlkermes Announces Appointment of Anne C. Whitaker to Board of Directors

    Source: Alkermes plc

13. 13
    2026-09-16 06:00 EST

    BIIBLEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

    Source: Biogen

14. 14
    2026-09-15 13:00 EST

    CLNNClene Announces $4 Million Registered Direct Offering

    Source: Clene Inc.

15. 15
    2026-09-14 12:03 EST

    TEVATeva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

    Source: Teva Pharmaceutical Industries

16. 16
    2026-09-14 11:00 EST

    KTTAPasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

    Source: Pasithea Therapeutics

17. 17
    2026-09-10 20:00 EST

    ABOSAcumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026

    Source: Acumen Pharmaceuticals

18. 18
    2026-09-10 12:30 EST

    VTGNVistagen to Present at Psych Congress 2026

    Source: Vistagen Therapeutics, Inc.

19. 19
    2026-09-10 12:00 EST

    ECORelectroCore to Participate at H.C. Wainwright Global Investment Conference

    Source: electroCore

20. 20
    2026-09-10 11:00 EST

    ALKSAlkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program

    Source: Alkermes plc

Companies in CNS

92 companies tagged with CNS.

Frequently Asked Questions